Indian Journal of Urology
SYMPOSIUM
Year
: 2010  |  Volume : 26  |  Issue : 1  |  Page : 98--101

Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis


John P Fitzgerald, Barbara Ercole, Dipen J Parekh 
 Department of Urology, University of Texas Health Science Center at San Antonio, Texas, USA

Correspondence Address:
Dipen J Parekh
Doctors Hospital at Renaissance Distinguished University Chair in Urology, Director of Robotic Surgery, Fellowship Director, Urologic Oncology, Associate Professor, Department of Urology, University of Texas Health Sciences Center at San Antonio, Texas
USA

The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.


How to cite this article:
Fitzgerald JP, Ercole B, Parekh DJ. Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis.Indian J Urol 2010;26:98-101


How to cite this URL:
Fitzgerald JP, Ercole B, Parekh DJ. Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis. Indian J Urol [serial online] 2010 [cited 2019 Aug 22 ];26:98-101
Available from: http://www.indianjurol.com/article.asp?issn=0970-1591;year=2010;volume=26;issue=1;spage=98;epage=101;aulast=Fitzgerald;type=0